Thrombosis
From the Journals
Evidence builds linking anticoagulation to COVID-19 survival
“Any family of mine who will have this disease absolutely will be on antithrombotic therapy and, actually, so are all of the patients at Mount...
News
COVID-19–associated coagulopathy
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
Conference Coverage
Predictors of ICH after thrombectomy identified
The sum of three variables may predict which patients undergoing thrombectomy up to 24 hours after a stroke are at higher risk of developing...
Conference Coverage
AUGUSTUS: After ACS or PCI, aspirin gives AFib patients scant benefit
Adding aspirin to an anticoagulant and P2Y12 inhibitor showed no net benefit, even acutely, suggesting need to target aspirin to highly selected...
From the Journals
ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients
News
Mislabeled clopidogrel lot recalled, may contain simvastatin
Conference Coverage
PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis
Conference Coverage
TWILIGHT-COMPLEX: Tap ticagrelor monotherapy early after complex PCI
“We found that the aspirin just doesn’t add that much, even in complex patients – just bleeding complications, for the most part.”
Conference Coverage
National Watchman registry reports impressive procedural safety
In-hospital stroke rate was just 0.17%, even though the registry patients were slightly older and sicker than those in clinical trials.
Conference Coverage
CARAVAGGIO expands DOAC pool in cancer-related VTE
Conference Coverage
Safe to skip post-TAVR clopidogrel in patients on OAC for atrial fib: POPULAR-TAVI